Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | APEX1 | P27695 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM6B | O15054 | 1/20 | 0.37 |
| ▸ | KDM5C | P41229 | 1/20 | 0.37 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.37 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | DGKA | P23743 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23527758 | 0.98 | TSHR (0.61) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL195299 | 0.96 | TSHR (0.53) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL40323 | 0.93 | THRB (0.53) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL28001101 | 0.93 | THRB (0.53) | TSHRPOLBAPEX1HTTTDP1 | |
| Succinic Acid SCHEMBL28001100 | 0.93 | THRB (0.53) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL2533209 | 0.93 | TSHR (0.66) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL195071 | 0.91 | TSHR (0.56) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL10708383 | 0.91 | THRB (0.52) | TSHRPOLBAPEX1HTTTDP1 | |
| Ethylene SCHEMBL19516917 | 0.91 | THRB (0.52) | TSHRPOLBAPEX1HTTTDP1 | |
| Ethylene SCHEMBL19516611 | 0.91 | THRB (0.52) | TSHRPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| EP-4114825-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| US-11209734-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11209733-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11204554-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-21 | — | — | US | disclosed |
| EP-3914965-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2021-12-01 | — | — | EP | disclosed |
| WO-2021175855-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-09-10 | — | — | WO | disclosed |
| WO-2021099233-A1 | METHOD FOR FABRICATING A PARTICLE | MERCK PATENT GMBH (DE) | 2021-05-27 | — | — | WO | disclosed |
| US-10793555-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2020-10-06 | — | — | US | disclosed |
| WO-2006024617-A1 | COMPOSITIONS CONTAINING ANTHRAQUINONE DYES | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006024618-A1 | CYANOPYRIDINE-BASED AZO DYES | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006024619-A1 | COMPOSITIONS CONTAINING PHTHALOCYANINE DYES | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006018405-A1 | OXIME ESTER PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-02-23 | — | — | WO | disclosed |
| CN-1720245-A | Oxime ester photoinitiators with heteroaryl groups | CIBA SC HOLDING AG (CH) | 2006-01-11 | — | — | CN | disclosed |
| EP-1567518-A2 | OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS | Ciba SC Holding AG (CH) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004050653-A2 | OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-06-17 | — | — | WO | disclosed |
| US-6602643-B2 | Useful as a protective material for etching, as back-coating material in the production of a shadow mask | TAIYO INK MANUFACTURING CO., LTD. (JP) | 2003-08-05 | — | — | US | disclosed |
| US-20020146629-A1 | Ultraviolet-curable resin composition | TAIYO INK MANUFACTURING CO., LTD. (JP) | 2002-10-10 | — | — | US | disclosed |
| EP-1219680-A1 | ULTRAVIOLET-CURABLE RESIN COMPOSITION | Taiyo Ink Manufacturing Co. Ltd (JP) | 2002-07-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11209734-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | TSHR 528/4885POLB 961/4885APEX1 485/4885 |
| US-11204554-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | TSHR 519/4885POLB 963/4885APEX1 502/4885 |
| US-10793555-B2 | Oxime ester photoinitiators | NR2E3, OXER1, CBR3 | TSHR 310/4885POLB 1874/4885APEX1 463/4885 |
| US-11209733-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | TSHR 528/4885POLB 961/4885APEX1 485/4885 |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | TSHR 2202/4885POLB 1333/4885APEX1 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.